Neonatal Thermoregulation Market Will Achieve US$ 800 Mn by 2027 | Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare, International Biomedical

Future Market Insights presents a new report titled 'Neonatal Thermoregulation Market: Global Industry Analysis 2012 – 2016 and Opportunity Assessment 2017 – 2027' that studies the performance of the global n eonatal thermoregulation market over a 10 year assessment period from 2017 to 2027. The report presents the value forecasts of the global neonatal thermoregulation market and provides pertinent insights into the various factors driving market growth as well as the factors restricting market growth. As per the assessment of Future Market Insights, the global neonatal thermoregulation market was estimated to be valued at nearly US$ 500 Mn in 2017 and is expected to reach a valuation of about US$ 800 Mn by 2027, and in the process exhibit a CAGR of 5.0% during the period of forecast 2017-2027.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5881

International Companies Targeting Emerging Economies for Lucrative Opportunities in the Neonatal Thermoregulation Market

The companies involved in the manufacturing and marketing of neonatal care equipment are shifting their focus towards emerging economies such as China, India, South Africa, Brazil and Mexico. Multinational companies are especially targeting the Asian markets for developing neonatal infant care equipment due to a significant demand and a potentially large customer base. For instance, in 2013, Koninklijke Philips N.V. entered the mother and childcare business segment, where it manufactures infant warms and incubators at affordable prices as compared to other market players in India. In December 2013, the GE Healthcare designed models to improve quality of neonatal care. The company launched two products for neonatal care in India, the new Lullaby Warmer Prime, and Lullaby Resus. The cost was about 40% lower than the existing offerings from GE, so that the products are easily accessible in low-middle income economic countries. Companies in the Asia Pacific region are developing innovative solutions to meet the growing needs of the neonatal care and treatment market. Companies, such as MTTS Asia and Pluss Advanced Technologies Pvt. Ltd. have developed innovative products, such as Miracradle and MTTS Firefly, catering to the demand for cooling systems in the region.

Global Neonatal Thermoregulation Market: Segmentation and Forecast

The global neonatal thermoregulation market is segmented on the basis of product type, modality, end user and geography.

By product type, the neonatal incubators segment was estimated to be valued at nearly US$ 250 Mn in 2017 and is likely to reach a valuation of nearly US$ 410 Mn in 2027, exhibiting a CAGR of 5.2% during the period of assessment 2017-2027.

By modality, the closed segment was estimated to be valued at nearly US$ 270 Mn in 2017 and is anticipated to witness a CAGR of 4.7% during the period of forecast.

By end user, the hospitals segment is expected to reach a valuation of nearly US$ 430 Mn in 2027.

By geography, the Asia Pacific neonatal thermoregulation market was estimated to be valued at nearly US$ 170 Mn in 2017 and is likely to reach a valuation of about US$ 295 Mn in 2027, exhibiting a CAGR of 5.5% during the period of forecast.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-5881

Global Neonatal Thermoregulation Market: Competitive Landscape

In this report, some of the important companies functioning in the global neonatal thermoregulation market have been profiled in the competitive landscape section. Some of the prominent companies that have been featured include GE Healthcare, Natus Medical Incorporated., Inspiration Healthcare Group plc, Koninklijke Philips N.V., Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare, International Biomedical, Ltd., Atom Medical Corporation, Fanem Ltda, Novos Medical Systems, Pluss Advanced Technologies Pvt. Ltd., Weyer GmbH, BabyBloom Healthcare BV and Medical Technology Transfer and Services Asia.

Report Page @ https://www.futuremarketinsights.com/reports/neonatal-thermoregulation-market

About Us

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.

FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Contact Us

U.S. Office

616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989,

United States

T: +1-347-918-3531

F: +1-845-579-5705

Email: sales@futuremarketinsights.com

Web: https://www.futuremarketinsights.com/

This release was published on openPR.